title: Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand.
abstract: Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.
authors.affiliation: Australian Research Centre for Health of Women and Babies, Discipline of Obstetrics and Gynaecology, Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia. emily.bain@adelaide.edu.au
authors.forename: Emily
authors.initials: E
authors.lastname: Bain
authors.forename: Tanya
authors.initials: T
authors.lastname: Bubner
authors.forename: Pat
authors.initials: P
authors.lastname: Ashwood
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Crowther
authors.forename: Philippa
authors.initials: P
authors.lastname: Middleton
mesh_terms: D001315:Australia; D002547:Cerebral Palsy / Q000517:prevention & control; D005260:Female; D019983:Guideline Adherence / Q000458:organization & administration / Q000706:statistics & numerical data*; D019538:Health Care Surveys; D006771:Hospitals, Maternity / Q000592:standards* / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009520:New Zealand; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods / Q000592:standards*; D062606:Tertiary Care Centers / Q000592:standards / Q000706:statistics & numerical data
chemical_list: D018696:Neuroprotective Agents; D008278:Magnesium Sulfate